NCIt definition : The mesylate salt of rivoceranib, an orally bioavailable, small-molecule receptor
tyrosine kinase inhibitor with potential antiangiogenic and antineoplastic activities.
Rivoceranib selectively binds to and inhibits vascular endothelial growth factor receptor
2, which may inhibit VEGF-stimulated endothelial cell migration and proliferation
and decrease tumor microvessel density. In addition, this agent mildly inhibits c-Kit
and c-SRC tyrosine kinases.;
UNII : TK02X14ASJ;
InChIKey : FYJROXRIVQPKRY-UHFFFAOYSA-N;
CAS number : 1218779-75-9; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1218779-75-9
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;